EUVIMED · CrossrefZeitschrift
Atherosclerosis Supplements
ISSN 1567-5688 · Elsevier BV
Neueste Artikel
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia
Large artery stiffness according to different assessment methods in adult population of St.Petersburg
The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia
CaRe high – Cascade screening and registry for high cholesterol in Germany
Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL
Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective
Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells
Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension
Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresis
We-P14:429 Despite its instability, epigallocatechin gallate effective lowers serum cholesterol in the hypercholesterolaemic rabbit
Do pregnancy complications and CVD share common antecedents?
Comparative pharmacology of rosuvastatin
Cardiovascular risk—through the ages
HDL: a recipe for longevity
Gene therapy and CVD: how near are we?
Insights from apoB: from better diagnosis & therapy to the Medusa Hypothesis
Impact of age on cardiovascular risk: implications for cardiovascular disease management
Abstracts
Lectures in the 3rd Baltic Atherosclerosis Congress Supplement
Contents
Congratulatory Address
Introductory remarks
Profile of Dr. Akira Endo
A tribute to Akira Endo, discoverer of a “Penicillin” for cholesterol
A letter from America to Dr. Endo
A unique cholesterol-lowering agent that no one had ever had before
Penicillin for hypercholesterolemia
EUVIMED